Abstract
A genome-wide association study (GWAS) was performed for 235 Dalmatian dogs using the canine Illumina high density bead chip to identify quantitative trait loci (QTL) associated with canine congenital sensorineural deafness (CCSD). Data analysis was performed for all Dalmatian dogs and in addition, separately for brown-eyed and blue-eyed dogs because of the significant influence of eye colour on CCSD in Dalmatian dogs. Mixed linear model analysis (MLM) revealed seven QTL with experiment-wide significant associations (-log10P>5.0) for CCSD in all Dalmatian dogs. Six QTL with experiment-wide significant associations for CCSD were found in brown-eyed Dalmatian dogs and in blue-eyed Dalmatian dogs, four experiment-wide significant QTL were detected. The experiment-wide CCSD-associated SNPs explained 82% of the phenotypic variance of CCSD. Five CCSD-loci on dog chromosomes (CFA) 6, 14, 27, 29 and 31 were in close vicinity of genes shown as causative for hearing loss in human and/or mouse.
Introduction
Canine congenital sensorineural deafness (CCSD) is the most common cause of deafness in dogs and has been identified in more than 90 dog breeds with highest prevalences in Dalmatian dogs, English setters, English cocker spaniels, bull terriers, Australian cattle dogs, Whippets, Catahoula leopard dogs, border collies and Jack Russell terriers [1]–[3]. Dalmatian dogs are known to be afflicted from CCSD more often than other dog breeds [1]–[10]. An association between phenotypic traits and sensorineural hearing loss had been proven as the occurrence of at least one blue eye leads to a significantly higher deafness prevalence and therefore is a prominent risk factor to CCSD [2]–[3], [5]–[9]. The risk to be affected by CCSD is 2.7-times higher for blue-eyed Dalmatian puppies than in brown-eyed Dalmatian puppies [8]. In addition, presence of blue eye colour showed a genetic correlation with CCSD of 0.53 indicating that genes causing the lack of melanocytes in the eyes may play a role for CCSD [8]. Histological findings classified CCSD as Scheibe dyplasia or cochleo-saccular degeneration characterized by an initial destruction of the stria vascularis, the lateral wall of the scala media of the cochlea. The strial degeneration is followed by a degeneration of the organ of Corti, a collapse of Reissner's membrane and eventually a collapse of the whole cochlear duct. The reason for the stria vascularis degeneration has not yet been completely clarified, but absence of intermediate cells (melanocytes) is assumed to be a main factor [1], [11]–[15]. Melanocytes are the only cell type in the stria vascularis that express the potassium channel protein KCNJ10. Elimination of Kcnj10 in knockout-mice reduced endolymph potassium levels and may be the direct cause of deafness [16].
In addition, primary degenerative defects of the tectorial membrane and of the inner ear hair cells were identified to lead to CCSD in Dalmatian dogs [11], [13]. Inheritance of CCSD in Dalmatian dogs appears to be complex with heritabilities at h2 = 0.20–0.34 [7]–[10]. A complex segregation analysis revealed a mixed monogenic-polygenic inheritance with a major recessive gene as the best model to explain inheritance of CCSD after introducing eye colour as covariate [9]. Genes causative for CCSD in dogs have not yet been identified [1]–[3]. Previous studies found mutations in genes on dog chromosomes (CFA) 10 (SILV, premelanosome proteinhttp://www.genenames.org/data/hgnc_data.php?hgnc_id=11190), 15 (KITLG, KIT ligand) and 20 (MITF, microphthalmia–associated transcription factor) associated with pigmentation patterns. However, none of these mutations provided an explanation for the occurrence of CCSD [1], [3], [17]–[21]. Neither in SOX10 (sex determining region Y)-box 10, located on CFA10), which is one of the genes involved in Waardenburg syndrome [1] and a candidate gene for CCSD in Australian stumpy-tail cattle dogs [19] nor in KITLG which is linked to the Irish spotting phenotype, were found mutations explaining CCSD [1]. Approximately 3.5-kb upstream of the M promoter of MITF, two mutations associated with pigmentation patterns were determined [20]. Within the 100 kb region containing MITF, a microsatellite marker has been reported to show a weak association with CCSD in Dalmatian dogs [21].
Much progress has been made in identifying genes causal for human deafness related to syndromic or non-syndromic hearing impairment [22]–[29], but little is known about the complex forms of hearing loss and their genetics (The Hereditary Hearing Loss Homepage: http://webhost.ua.ac.be/hhh/). Currently 135 loci and 55 genes for monogenic forms of human deafness have been identified.
The objective of the present genome-wide association study (GWAS) was to identify loci associated with CCSD in Dalmatian dogs employing the canine high density Illumina bead chip (Illumina, San Diego, CA, USA). Within these loci and their vicinity, we searched for functional candidate genes that play a role in human deafness and genes that are involved in the development of the inner ear as well as in the differentiation and migration of melanoblasts.
Results
An mixed linear model (MLM) analysis across all Dalmatian dogs revealed seven loci on dog chromosomes (CFA) 2, 6 (68 Mb), 14, 17, 27 (9 Mb), 29 and 31 as experiment-wide significant as well as three loci on CFA6 (45 Mb), 18 and 27 (25 Mb) did reach –log10P-values >4.0 (Table S1). The GWAS using a MLM analysis for brown-eyed Dalmatian dogs discovered five loci on dog chromosomes (CFA) 2, 6 (two loci), 27 and 29 for CCSD (Figure 1). In addition, the QTL on CFA14 was experiment-wide significantly associated with CCSD in Dalmatian dogs with brown eye colour when the dependent variate accounted for unilaterally and bilaterally affected dogs (Figure 2). These six loci had been also identified using the MLM without accounting for eye color. Four CCSD-loci were detected on CFA17, 18, 27 and 31 for blue-eyed Dalmatian dogs employing a MLM analysis (Figure 3). These four loci detected by the MLM analysis stratified for blue eye colour were also consistent with the loci found in the MLM analysis across all Dalmatian dogs. A summary of CCSD-associated loci is shown in Table S2. All –log10P-values of the MLM analyses were corrected for multiple testing using the adaptive false discovery rate according to Benjamini-Hochberg. The thresholds for experiment-wide significance at P-values <0.05, 0.01 and 0.001 were at observed –log10P-values >5.0, 6.3 and 8.0. The observed -log10P-values were plotted against the expected -log10P-values and the quantile-quantile plots indicated that the population stratification was eliminated through the identity-by-state (IBS) kinship matrix and the fixed effect of sex (Figures S1–S3). On CFA2, there were two experiment-wide significantly CCSD-associated SNPs within an interval of 19.778 kb and a further significant CCSD-SNP at 13.139 Mb of the CanFam3.1 genome assembly. On CFA6 at 69 Mb, there were 19 experiment-wide significantly CCSD-associated SNPs within an interval of 1.287 Mb. On CFA17, eight SNPs within an interval of 1.830 Mb, on CFA18 six SNPs within an interval of 1.012 Mb, on CFA27 two SNPs within an interval of 0.018 Mb and on CFA31 seven SNPs within an interval of 0.743 Mb were experiment-wide significantly associated with CCSD.
In Table 1, from each QTL the SNP with the highest –log10P-value from the MLM analysis is given. The odds ratios (ORs) stratified by sex were determined to demonstrate the impact of the significantly associated SNPs on CCSD. The ORs for CCSD in Dalmatian dogs with brown eyes were at 1.18–10.70 and for blue-eyed Dalmatian dogs at 1.73–7.85. The single SNPs with the highest –log10P-values from each QTL explained between 11 and 14% of the phenotypic variance for CCSD in brown-eyed Dalmatian dogs and the respective SNPs for blue-eyed Dalmatian dogs between 15 and 26%. The SNP BICF2P176848 on CFA2 explained the largest proportion of variance for brown-eyed Dalmatian dogs and for blue-eyed Dalmatian dogs, the SNP BICF2G630740465 on CFA31. The variance explained by all experiment-wide significant SNPs for brown-eyed Dalmatian dogs was at 65.5% in a general linear model, for blue-eyed Dalmatian dogs at 64.4% and for all Dalmatian dogs at 82.4%.
Table 1. Summary of results for the genome-wide association study using a mixed linear model and a sex-stratified case-control analysis for canine congenital sensorineural deafness in Dalmatian dogs.
Trait | Position | Position | SNP-ID | Minor allele | MAF | MAFa | MAFu | VE | OR | CI-L | CI-U | -log10P | Candidate gene | Distance to the nearest candidate gene in Mb |
CFA | CanFam3.1 | CanFam2.0 | ||||||||||||
Deafness in brown eyed dogs | ||||||||||||||
2 | 13,786,700 | 16,675,682 | BICF2P176848 | T | 0.08 | 0.19 | 0.03 | 0.14 | 7.76 | 3.48 | 17.30 | 6.15 | ARHGAP12 | 1.19 (-) |
6 | 45,474,835 | 48,537,551 | TIGRP2P83893_RS8732055 | A | 0.49 | 0.69 | 0.42 | 0.12 | 3.13 | 1.96 | 5.00 | 5.09 | COL11A1 | 1.95 (−) |
6 | 68,927,940 | 71,986,567 | BICF2P590845 | A | 0.14 | 0.15 | 0.13 | 0.13 | 1.30 | 0.71 | 2.33 | 5.68 | GIPC2 | 0.06 (+) |
14 | 39,561,348 | 42,518,712 | BICF2G630529431 | T | 0.17 | 0.13 | 0.18 | 0.13 | 1.41 | 0.77 | 2.56 | 5.85 | DFNA5 | 1.29 (+) |
HOXA1 | 0.71 (−) | |||||||||||||
27 | 9,400,352 | 12,412,335 | BICF2S23410492 | C | 0.05 | 0.17 | 0.02 | 0.11 | 10.70 | 3.87 | 29.6 | 5.80 | TWF1 | 0.88 (−) |
29 | 23,903,462 | 26,901,967 | BICF2G630625485 | T | 0.20 | 0.23 | 0.20 | 0.12 | 1.18 | 0.72 | 1.96 | 5.26 | GDAP1 | 1.07 (+) |
Deafness in blue eyed dogs | ||||||||||||||
17 | 28,929,911 | 32,032,913 | BICF2G630212376 | A | 0.11 | 0.17 | 0.08 | 0.17 | 2.20 | 0.78 | 6.25 | 5.41 | CRIM1 | intragenic |
18 | 51,795,260 | 54,820,227 | BICF2P28982 | G | 0.16 | 0.24 | 0.15 | 0.15 | 1.73 | 0.75 | 4.01 | 5.08 | CDC42EP2 | 0.06 (−) |
27 | 25,549,421 | 28,568,843 | BICF2P507470 | T | 0.11 | 0.35 | 0.07 | 0.15 | 7.85 | 3.40 | 18.1 | 5.32 | AEBP2 | 2.11 (−) |
31 | 30,836,962 | 32,955,387 | BICF2G630740465 | G | 0.20 | 0.44 | 0.16 | 0.26 | 4.18 | 1.94 | 8.98 | 8.13 | CLDN14 | 0.84 (−) |
The SNP-ID, the position on dog chromosome (CFA) in base pairs (bp) according to CanFam3.1 and CanFam2.0, minor allele, minor allele frequency (MAF) for all, affected (MAFa) and unaffected (MAFu) dogs (controls), variance explained by the respective SNP (VE) and -log10P-values (-log10P) from the mixed linear model analysis and positional candidate genes with their distance to the CCSD-associated SNP are given. SNPs downstream of the nearest candidate gene are marked with a plus sign (+) and SNPs upstream of the nearest candidate gene are marked with a minus sign (−). Odds ratios (OR) are from a case-control study stratified by sex with 95% confidence intervals (CI).
Haplotype structure and haplotype association were analyzed for all ten genomic regions surrounding the significantly associated SNPs (Figures 4, 5, 6, 7, 8, 9, 10, 11, 12, 13). The SNPs BICF2P176848 on CFA2, TIGRP2P83893_RS8732055 on CFA6 and BICF2P507470 on CFA27 reside within a significantly (P-value<0.05 after 10,000 permutations) CCSD-associated haplotype block, respectively (Figures 4,5,12).
The cumulative distribution of CCSD-associated genotypes per individual dog among affected and unaffected animals shows that at least one CCSD-predisposing genotype significantly increases the risk to CCSD (Figure 14). In the case that Dalmatian dogs carry more than one CCSD-associated genotype, nearly all of them are affected. The distribution of the SNP-genotypes also shows that animals with susceptible genotypes are at high risk to CCSD (Table S3 and S4).
Discussion
The present GWAS for CCSD in Dalmatian dogs identified seven experiment-wide significant CCSD-loci for Dalmatian dogs, whereof six were experiment-wide significant for brown-eyed Dalmatian dogs and four experiment-wide significant for blue-eyed Dalmatian dogs. The QTL among brown-eyed and blue-eyed Dalmatian dogs were located on different chromosomal positions and appeared largely independently associated with CCSD. The presence of at least one CCSD-predisposing genotype significantly increased the risk to CCSD. Therefore, we assume that several loci contribute to the complex inheritance of CCSD in Dalmatian dogs [7]–[10]. Our study is the first GWAS for CCSD in Dalmatian dogs and we can demonstrate that a large proportion of the phenotypic variation of this trait can be captured through the significantly associated SNPs.
The models we employed for the GWAS should fully account for the strong stratification of iris pigmentation on the prevalence of CCSD. Therefore, the association analyses were separately performed for brown-eyed and blue-eyed Dalmatian dogs. This type of parameterization allowed us to infer associations in dependence of eye pigmentation genes and to differentiate among loci causing genetic heterogeneity. An analysis across all Dalmatian dogs without taking into account the stratification caused by iris pigmentation may mask some loci or underestimate associations due to genetic heterogeneity. We employed an MLM analysis across all Dalmatian dogs without accounting for iris pigmentation in order to see which loci might be affected by this stratification effect. This analysis revealed the loci on CFA2, 6 (68 Mb), 14, 17, 27 (9 Mb), 29 and 31 as experiment-wide significant, whereas the loci on CFA6 (45 Mb), 18 and 27 (25 Mb) did not reach experiment-wide significance thresholds. Possibly, these latter loci on CFA6, 18 and 27 may be more strongly influenced by a segregation pattern which is different among Dalmatian dogs with different iris colour due to genetic heterogeneity. Accounting for eye colour may also facilitate replication studies as CCSD-predisposing alleles of some loci seem to be more common in blue-eyed versus brown-eyed Dalmatian dogs.
Hearing loss is unilateral or bilateral in Dalmatian dogs [1]–[10]. We observed a random segregation of the unilateral and bilateral CCSD-affection status in closely related dogs and thus a genetic correlation close to one. In addition, the GWAS showed very similar results treating all CCSD-affected individuals as cases or differentiating among unilaterally and bilaterally CCSD-affected cases. The distribution of CCSD-associated genotypes per individual dog suggested that dogs with bilateral hearing loss had CCSD-susceptible genotypes at several loci and therefore, accumulated a larger number of CCSD-predisposing alleles from several loci than dogs with unilateral hearing loss. These loci appeared randomly distributed without a clear pattern for a preference of specific loci. An unequal distribution of CCSD-associated alleles may be due to Mendelian segregation among full-sibs.
In agreement with previous studies we did not find experiment-wide significant associations with markers located within MITF, SILV, SOX10 and KITLG or in the neighbourhood of MITF, SILV and KITLG [17]–[21]. A marker in the vicinity of MITF showed an association at a nominal P-value<0.05 in German Dalmatian dogs but did not exceed the experiment-wide significance level [21]. This association could also be confirmed in the present data set (data not shown). The linkage interval on CFA10 in the Australian stumpy-tail cattle dog covered most of the chromosome and thus, SOX10 may be one of many other candidates [19].
Candidate genes were identified using the dog genome assembly build 3.1 [http://www.ensembl.org/Canis_familiaris/]. In the neighbourhood of four experiment-wide significant CCSD-loci, genes were found that are known to be involved in human hearing loss including COL11A1 (collagen type XI alpha 1) on CFA6, DFNA5 and HOXA1 (homeobox A1) on CFA14, GDAP1 (ganglioside induced differentiation associated protein 1) on CFA29 and CLDN14 (claudin-14) on CFA31. These genes are involved in the development and maintenance of inner ear structures [22]–[29].
Four CCSD-loci were close to genes influencing the migration of melanocytes and the melanosome transport [30]–[34]. An implication of these possible candidate genes for CCSD has not yet established but should drive further research. The role of genes influencing melanocyte differentiation and migration is worth further investigation as these genes may affect pathways of genes involved in Waardenburg syndrome (WS) [28]. Those genes are ARHGAP12 (Rho GTPase activating protein 12) on CFA2, TWF1 (twinfilin, actin-binding protein, homolog 1 (Drosophila)) on CFA27, CDC42EP2 on CFA18 and AEBP2 (AE (adipocyte enhancer) binding protein 2) on CFA27.
Further two genes, GIPC2 (GIPC PDZ domain containing family, member 2) on CFA6 and CRIM1 (cysteine rich transmembrane BMP regulator 1 (chordin-like)) on CFA17 showed significant associations through SNPs located within these genes. CRIM1 is associated with pleiomorphic phenotypes in mutant mice [35] and possibly with melanoblast migration [36].
DFNA5, COL11A1 and HOXA1 influence cochlear development and morphogenesis, and cause sensorineural hearing loss in humans when mutated. Gain of function mutations in DFNA5 lead to pathological programed cell death in the differentiated auditory sensory epithelium of the organ of Corti [37]–[41], while dominant mutations in COL11A1 cause the production of mutant collagen resulting in abnormally arranged collagen fibrils within the tectorial membrane [42]–[47]. Truncating mutations in HOXA1 are associated to malformations of the inner ear [48]–[49]. The CCSD-locus on CFA14 is located in between the genes DFNA5 and HOXA1 and its association is due to bilaterally deaf Dalmatian dogs and thus, these dogs may be affected by mutations of both genes, DFNA5 and HOXA1.
Mutations in the gene GDAP1 are involved in the Charcot-Marie-Tooth disease (CMT) type 2 K and 4 A in humans that is characterized by progressive hypo- and demyelination resulting in motor and sensory neuropathy. Rare cases of CMT show neural deafness as a clinical feature in addition to other symptoms [50]–[51].
Within the QTL on CFA6 at 69 Mb, GIPC2 is located. Even if this gene has no obvious known contribution to CCSD, it may possibly influence the maintenance of inner ear structures as mutations in its family members, GIPC1 and GIPC3, are able to cause sensorineural hearing loss due to degeneration of hair cells and ganglion neurons of the nervus cochlearis [52]–[55].
The candidate genes ARHGAP12 and TWF1 on CFA2 and CFA27 possibly interact due to cytoskeletal organisation during melanocyte migration and melanosome transfer. The association of piebaldism with deafness may be due to the lack of melanoblast-derived intermediate cells of the stria vascularis because degeneration of the organ of Corti is observed in several mouse models when these cells are missing [56]. The formation of lamellipodia, filopodia and stress fibres is essential for melanocyte functions. Changes of cell shape emerge from cytoskeletal organization orchestrated by the family of GTPases, like Rac, Rho or Cdc42 [57]. ARHGAP12 is able to regulate Rho, which induces dissolution of stress fibres [58]. Furthermore, TWF1 is regulated by the small GTPases Rac1 and Cdc42 and is involved in cell shape modification [59]. Interestingly, the family member Twinfilin2 (TWF2) influences the development and maintenance of sterocilia. Sterocilia are actin filled and positioned on the apical surface of hair cells required for mechanoelectrical transduction within the inner ear [29], [60]. However, cytoskeletal rearrangement orchestrated by TWF1 might be involved in melanocyte dendricity but also hair-bundle development.
In blue-eyed Dalmatian dogs, the GWAS detected a QTL close to CLDN14. Mutations of CLDN14 cause sensorineural hearing loss in human and mice. Hearing loss in these cases is due to rapid degeneration of the outer hair cells and later on, of the inner hair cells [61]–[65].
The candidate genes on CFA18 and 27 play a role in melanocyte dendricity and development. The CFA18 candidate gene CDC42EP2 interacts with the small GTP-binding protein Cdc42. Activated Cdc42 is associated with changes in the cytoskeleton of melanocytes and is able to stimulate filopodia formation for melanocyte dendricity [57], [66]–[67].
The further candidate gene on CFA27, Aebp2 is expressed in neural crest cells of the developing mouse embryo. Mutations in Aebp2 in mice result in an enlarged colon, hypopigmentation and auditory defects similar to human Hirschsprung's disease and Waardenburg syndrome. Melanoblasts migrate from the neural crest through several pathways to the skin, the iris and choroids of the eye, and the inner ear. An alteration of these pathways causes the absence of melanocytes and thus depigmented areas and deafness in human and mouse [28], [29], [68]–[69].
The candidate gene CRIM1 on CFA17 interacts with members of the transforming growth factor beta family and plays a role in tissue development of the eye of mice [35], [70]. Furthermore, a recent study identified CRIM1 to be involved in eye area pigmentation in Fleckvieh cattle [36].
All these aforementioned candidate genes for CCSD in Dalmatian dogs share interactions mediated by co-expression as shown by a network analysis using Genemania (http://www.genemania.org).
In conclusion, the GWAS suggested that different loci may be independently associated with CCSD in Dalmatian dogs. Thus, non-allelic heterogeneity may be the underlying mode for the complex inheritance of CCSD in the Dalmatian dog. We found support for candidate genes involved in the development of the tectorial membrane, sensory epithelium of organ of Corti and ganglion neurons as well as the maintenance of cochlear hair cells. To clarify a possible involvement of these candidate genes and genes regulating cytoskeletal rearrangement and migration of melanocytes requires further research in larger samples and deep sequencing of the candidate genomic regions. The genetic approach in the Dalmatian dog may open the way to decipher the molecular mechanisms underlying CCSD and then this dog breed may be a suitable animal model for further studies in human sensorineural hearing loss.
Materials and Methods
Ethics Statement
All animal work was conducted according to national and international guidelines for animal welfare. The dogs of this study were included with the consent of their owners. The BAER test (brainstem auditory evoked response test) was performed in veterinary clinics. BAER testing is mandatory for all Dalmatian dogs in Germany. The blood samples were taken by veterinarians during routine examinations for the BAER test referring to good veterinary practice. Approval from the ethics committee was not obtained because blood sampling was during a diagnostic veterinary procedure according to the German Animal Welfare Law (released on 05/18/2006, last changes on 12/09/2010).
Animals
In the present study, 235 Dalmatian dogs with a definitive diagnosis for CCSD were included (Table 2). Among these were 157 Dalmatian dogs with normal hearing and either brown or blue eye colour, and 61 brown-eyed dogs and 17 blue-eyed Dalmatian dogs with unilaterally or bilaterally hearing loss. The animals were balanced according to sex, ancestry and hearing loss. All dogs in the present study were not related up to the grandparent level. All Dalmatian dogs genotyped were screened for unilateral and bilateral hearing loss by trained veterinarians using the BAER test. The test was performed in six to eight weeks old puppies under general anaesthesia with xylazine and ketamine. Each ear was tested individually after obvious cases of conductive deafness were excluded using otoscopy. Standard ear phones and acquisition measurement conditions were used as well as same stimulus click rates with 30 clicks per second and 1000 clicks per ear. Stainless steel subdermal needle electrodes were used for recording. Clicks were presented at 80 db normal hearing level (nHL) to an individual ear. White noise, at 30 db lower than the stimulus, was delivered into the non tested ear to avoid crossover recordings from a functional contralateral ear. Conductive deafness was excluded using bone-conduction stimulation via a vibrator. Bone-conduction stimulation was employed through removing the vibration unit from the headset and placing it on the mastoid process of the tested ear [71], [72]. The waveform responses recorded within the first 10 ms consists of up to seven waves in normal hearing dogs [73]. Dogs with an essential flat line without any identifiable waveforms were diagnosed as deaf for the respective ear. Puppies with inexplicit test results were retested at an age of three to four months. All the puppies were classified as hearing, unilaterally deaf or bilaterally deaf.
Table 2. Number of Dalmatian dogs genotyped on the canine Illumina high density beadchip.
Trait | Male | Female | Total |
Control | 74 | 83 | 157 |
Uni- or bilateral CCSD and brown eye colour | 29 | 32 | 61 |
Uni- or bilateral CCSD and blue eye colour | 8 | 9 | 17 |
Only bilateral CCSD | 10 | 12 | 22 |
Only bilateral CCSD and brown eye colour | 9 | 8 | 17 |
Number of dogs stratified by sex, eye colour and canine congenital sensorineural deafness (CCSD). CCSD can be unilateral or bilateral. In addition to all cases of hearing loss including both, unilateral or bilateral cases, bilateral CCSD cases (n = 22) and bilateral CCSD cases with brown eye colour (n = 17) are given.
DNA preparation and Genotyping
Genomic DNA was extracted from EDTA-blood samples through a standard ethanol fractionation with concentrated sodium chloride (6 M NaCl) and sodium dodecyl sulphate (10% SDS). Concentration of extracted DNA for SNP chip analysis was adjusted to 50 ng/µl using Nanodrop ND-1000 (Peqlab Biotechnology, Erlangen, Germany).
Genotyping for the 235 Dalmatian dogs was performed using the canine Illumina high density beadchip (Illumnia) with 173,662 SNPs. Quality control (QC) criteria were minor allele frequencies (MAF) >0.05, genotyping rate per SNP and animal >0.90 and Hardy-Weinberg equilibrium (P-value<0.000001). These QC criteria were met by 106,435 SNPs and this number of SNPs was used for all statistical analyses. Chromosomal positions of the SNPs were determined using the canis lupus familiaris genome assembly CanFam3.1 (http://www.ensembl.org/Canis_familiaris/) and BLASTN (http://www.ensembl.org/Multi/blastview).
Statistical Analysis
The ALLELE procedure of SAS/Genetics, version 9.3 (SAS Institute, Cary, NC, USA), was used to calculate polymorphism information content, heterozygosity, allelic diversity, allele and genotype frequencies and χ2-tests for Hardy-Weinberg-Equilibrium. The genome-wide association analyses were performed using a mixed linear model (MLM) using TASSEL, version 3.0.88 [74]. Analyses were done for brown-eyed and blue-eyed dogs separately and encoding dogs with normal hearing status as controls and dogs with unilateral or bilateral hearing loss as cases. A further GWAS for brown-eyed dogs was employed encoding controls with 1, unilaterally CCSD-affected with 2 and bilaterally CCSD-affected with 3 in order to account for the number of ears with CCSD. The MLM included the fixed effects of sex, SNP-genotype and the random animal effect via the identity-by-state-kinship (IBS) matrix. The IBS matrix reflects the genomic relationship matrix among all individuals genotyped and captures the relatedness among animals as well as the cryptic family structure. The variance explained by each SNP was calculated employing the MLM. The adaptive false discovery rate according to Benjamini-Hochberg was calculated using the MULTIPLE TEST procedure of SAS, version 9.3, to determine the threshold for experiment-wide significance. The CASECONTROL procedure of SAS/Genetics, version 9.3, was used to calculate ORs with their 95% confidence intervals using sex as strata. The proportion of variance explained by all the CCSD-associated SNPs was jointly estimated using a general linear model and comparisons of the residual variances of the reference model with sex only (VR) to the models with sex and the respective SNP genotype effects (VF). The proportion of variance explained by the respective SNP genotypes was calculated as 1-(VF/VR). We analysed the haplotype structure of the identified QTL and their flanking genomic regions spanning 1–2 Mb and tested the association of haplotype blocks to CCSD with a permutation rate of 10.000 using Haploview 4.0 [75].
Supporting Information
Acknowledgments
The authors thank the breeding organizations for Dalmatian dogs in Germany, namely the Club für Dalmatiner-Freunde e.V. (CDF), Deutscher Dalmatiner Club von 1920 e.V. (DDC) and Dalmatiner Verein Deutschland (DVD), all Dalmatian breeders and owners for providing EDTA-blood samples, pedigree data and BAER test results. The support of the veterinary clinics in sample collection is gratefully acknowledged as well as the general support by the Verband für das Deutsche Hundewesen (VDH), Dortmund, for introducing the BAER testing program. We thank M. Drabert for his expert technical assistance.
Funding Statement
The study was supported by a grant of the Gesellschaft zur Förderung kynologischer Forschung (gkf) e.V., Bonn, and by the Club für Dalmatiner-Freunde e.V. (CDF-DI/2010-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Strain GM (2012) Canine deafness. Vet Clin North Am Small Anim Pract 42: 1209–1224. [DOI] [PubMed] [Google Scholar]
- 2. Strain GM (2004) Deafness prevalence and pigmentation and gender associations in dog breeds at risk. Vet J 167: 23–32. [DOI] [PubMed] [Google Scholar]
- 3. Rak SG, Distl O (2005) Congenital sensorineural deafness in dogs: a molecular genetic approach toward unravelling the responsible genes. Vet J 169: 188–196. [DOI] [PubMed] [Google Scholar]
- 4. Holliday TA, Nelson HJ, Williams DC, Willits N (1992) Unilateral and bilateral brainstem auditory-evoked response abnormalities in 900 Dalmatian dogs. J Vet Intern Med 6: 166–174. [DOI] [PubMed] [Google Scholar]
- 5. Strain GM, Kearney MT, Gignac IJ, Levesque DC, Nelson HJ, et al. (1992) Brainstem auditory-evoked potential assessment of congenital deafness in Dalmatians: associations with phenotypic markers. J Vet Intern Med 6: 175–182. [DOI] [PubMed] [Google Scholar]
- 6. Greibrokk T (1994) Hereditary Deafness in the Dalmatian: Relationship to eye and coat colour. J Am Anim Hosp Assoc 30: 170–76. [Google Scholar]
- 7. Muhle AC, Jaggy A, Stricker C, Steffen F, Dolf G, et al. (2002) Further contributions to the genetic aspect of congenital sensorineural deafness in Dalmatians. Vet J 163: 311–318. [DOI] [PubMed] [Google Scholar]
- 8. Juraschko K, Meyer-Lindenberg A, Nolte I, Distl O (2003) Analysis of systematic effects on congenital deafness in German Dalmatian dogs. Vet J 166: 164–169. [DOI] [PubMed] [Google Scholar]
- 9. Juraschko K, Meyer-Lindenberg A, Nolte I, Distl O (2003) A regressive model analysis of congenital sensorineural deafness in German Dalmatian dogs. Mamm Genome 14: 547–554. [DOI] [PubMed] [Google Scholar]
- 10. Cargill EJ, Famula TR, Strain GM, Murphy KE (2004) Heritability and segregation analysis of deafness in U.S. Dalmatians. Genetics 166: 1385–1393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Mair IW (1976) Hereditary deafness in the Dalmatian dog. Arch Otorhinolaryngol 212: 1–14. [DOI] [PubMed] [Google Scholar]
- 12. Lurie MD (1948) The membranous labyrinth in the congenital deaf Collie and Dalmatian dog. Laryngoscope 58: 279–287. [DOI] [PubMed] [Google Scholar]
- 13. Sampaio AL, Paine E, Schachern PA, Sutherland C, Cureoglu S, et al. (2010) Histopathological morphometric study of cochleosaccular dysplasia in Dalmatian dogs. Int J Pediatr Otorhinolaryngol 74: 934–938. [DOI] [PubMed] [Google Scholar]
- 14. Steel KP, Barkway C (1989) Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development 107: 453–463. [DOI] [PubMed] [Google Scholar]
- 15. Cable J, Huszar D, Jaenisch R, Steel KP (1994) Effects of mutations at the W locus (c-kit) on inner ear pigmentation and function in the mouse. Pigment Cell Res 7: 17–32. [DOI] [PubMed] [Google Scholar]
- 16. Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, et al. (2004) Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med 2: 30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Clark LA, Wahl JM, Rees CA, Murphy KE (2006) Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog. Proc Natl Acad Sci 103: 1376–1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Stritzel S, Wöhlke A, Distl O (2007) Elimination of SILV as a candidate for congenital sensorineural deafness in Dalmatian dogs. Anim Genet 38: 662–663. [DOI] [PubMed] [Google Scholar]
- 19. Sommerlad S, McRae AF, McDonald B, Johnstone I, Cuttell L, et al. (2010) Congenital sensorineural deafness in Australian stumpy-tail cattle dogs is an autosomal recessive trait that maps to CFA10. PLoS One 5: e13364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Karlsson EK, Baranowska I, Wade CM, Salmon Hillbertz NH, Zody MC, et al. (2007) Efficient mapping of Mendelian traits in dogs through genome-wide association. Nat Genet 39: 1321–1328. [DOI] [PubMed] [Google Scholar]
- 21. Stritzel S, Wöhlke A, Distl O (2009) A role of the microphthalmia-associated transcription factor in congenital sensorineural deafness and eye pigmentation in Dalmatian dogs. J Anim Breed Genet 126: 59–62. [DOI] [PubMed] [Google Scholar]
- 22. Petit C, Levilliers J, Hardelin JP (2001) Molecular genetics of hearing loss. Annu Rev Genet 35: 589–646. [DOI] [PubMed] [Google Scholar]
- 23. Steel KP, Kros CJ (2001) A genetic approach to understanding auditory function. Nat Genet 27: 143–149. [DOI] [PubMed] [Google Scholar]
- 24. Petit C (2006) From deafness genes to hearing mechanisms: harmony and counterpoint. Trends Mol Med 12: 57–64. [DOI] [PubMed] [Google Scholar]
- 25. Leibovici M, Safieddine S, Petit C (2008) Mouse models for human hereditary deafness. Curr Top Dev Biol 84: 385–429. [DOI] [PubMed] [Google Scholar]
- 26. Yan D, Liu XZ (2008) Cochlear molecules and hereditary deafness. Front Biosci 13: 4972–4983. [DOI] [PubMed] [Google Scholar]
- 27. Petit C, Richardson GP (2009) Linking genes underlying deafness to hair-bundle development and function. Nat Neurosci 12: 703–710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, et al. (2010) Review and update of mutations causing Waardenburg syndrome. Hum Mutat 31: 391–406. [DOI] [PubMed] [Google Scholar]
- 29. Richardson GP, de Monvel JB, Petit C (2011) How the genetics of deafness illuminates auditory physiology. Annu Rev Physiol 73: 311–334. [DOI] [PubMed] [Google Scholar]
- 30. Aspengren S, Hedberg D, Sköld HN, Wallin M (2009) New insights into melanosome transport in vertebrate pigment cells. Int Rev Cell Mol Biol 272: 245–302. [DOI] [PubMed] [Google Scholar]
- 31. Schiaffino MV (2010) Signaling pathways in melanosome biogenesis and pathology. Int J Biochem Cell Biol 42: 1094–1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Ho H, Ganesan AK (2011) The pleiotropic roles of autophagy regulators in melanogenesis. Pigment Cell Melanoma Res 24: 595–604. [DOI] [PubMed] [Google Scholar]
- 33. Ohbayashi N, Fukuda M (2012) Role of Rab family GTPases and their effectors in melanosomal logistics. J Biochem 151: 343–351. [DOI] [PubMed] [Google Scholar]
- 34. Sitaram A, Marks MS (2012) Mechanisms of protein delivery to melanosomes in pigment cells. Physiology (Bethesda) 27: 85–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Chiu HS, York JP, Wilkinson L, Zhang P, Little MH, et al. (2012) Production of a mouse line with a conditional Crim1 mutant allele. Genesis 50: 711–716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Pausch H, Wang X, Jung S, Krogmeier D, Edel C, et al. (2012) Identification of QTL for UV-protective eye area pigmentation in cattle by progeny phenotyping and genome-wide association analysis. PLoS One 7: e36346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Van Laer L, Huizing EH, Verstreken M, van Zuijlen D, Wauters JG, et al. (1998) Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet 20: 194–197. [DOI] [PubMed] [Google Scholar]
- 38. Yu C, Meng X, Zhang S, Zhao G, Hu L, et al. (2003) A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics 82: 575–579. [DOI] [PubMed] [Google Scholar]
- 39. Bischoff AM, Luijendijk MW, Huygen PL, van Duijnhoven G, De Leenheer EM, et al. (2004) A novel mutation identified in the DFNA5 gene in a Dutch family: a clinical and genetic evaluation. Audiol Neurootol 9: 34–46. [DOI] [PubMed] [Google Scholar]
- 40. Busch-Nentwich E, Söllner C, Roehl H, Nicolson T (2004) The deafness gene dfna5 is crucial for ugdh expression and HA production in the developing ear in zebrafish. Development 131: 943–951. [DOI] [PubMed] [Google Scholar]
- 41. Cheng J, Han DY, Dai P, Sun HJ, Tao R, et al. (2007) A novel DFNA5 mutation, IVS8+4 A>G, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family. Clin Genet 72: 471–477. [DOI] [PubMed] [Google Scholar]
- 42. Slepecky NB, Cefaratti LK, Yoo TJ (1992) Type II and type IX collagen form heterotypic fibers in the tectorial membrane of the inner ear. Matrix 12: 80–86. [DOI] [PubMed] [Google Scholar]
- 43. Thalmann I (1993) Collagen of accessory structures of organ of Corti. Connect Tissue 29: 191–201. [DOI] [PubMed] [Google Scholar]
- 44. Richards AJ, Yates JR, Williams R, Payne SJ, Pope FM, et al. (1996) A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum Mol Genet 5: 1339–1343. [DOI] [PubMed] [Google Scholar]
- 45. Annunen S, Körkkö J, Czarny M, Warman ML, Brunner HG, et al. (1999) Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet 65: 974–983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Martin S, Richards AJ, Yates JR, Scott JD, Pope M, et al. (1999) Stickler syndrome: further mutations in COL11A1 and evidence for additional locus heterogeneity. Eur J Hum Genet 7: 807–814. [DOI] [PubMed] [Google Scholar]
- 47. McGuirt WT, Prasad SD, Griffith AJ, Kunst HP, Green GE, et al. (1999) Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet 23: 413–419. [DOI] [PubMed] [Google Scholar]
- 48. Bosley TM, Salih MA, Alorainy IA, Oystreck DT, Nester M, et al. (2007) Clinical characterization of the HOXA1 syndrome BSAS variant. Neurology 69: 1245–1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Bosley TM, Alorainy IA, Salih MA, Aldhalaan HM, Abu-Amero KK, et al. (2008) The clinical spectrum of homozygous HOXA1 mutations. Am J Med Genet A 146A: 1235–1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Crimella C, Tonelli A, Airoldi G, Baschirotto C, D'Angelo MG, et al. (2010) The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K. J Med Genet 47: 712–716. [DOI] [PubMed] [Google Scholar]
- 51. Cassereau J, Chevrollier A, Bonneau D, Verny C, Procaccio V, et al. (2011) A locus-specific database for mutations in GDAP1 allows analysis of genotype-phenotype correlations in Charcot-Marie-Tooth diseases type 4A and 2K. Orphanet J Rare Dis 6: 87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Katoh M (2002) GIPC gene family (Review). Int J Mol Med 9: 585–589. [PubMed] [Google Scholar]
- 53. Kirikoshi H, Katoh M (2002) Up-regulation of GIPC2 in human gastric cancer. Int J Oncol 20: 1183–1187. [PubMed] [Google Scholar]
- 54. Naccache SN, Hasson T, Horowitz A (2006) Binding of internalized receptors to the PDZ domain of GIPC/synectin recruits myosin VI to endocytic vesicles. PNAS 103: 12735–12740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Charizopoulou N, Lelli A, Schraders M, Ray K, Hildebrand MS, et al. (2011) Gipc3 mutations associated with audiogenic seizures and sensorineural hearing loss in mouse and human. Nat Commun 2: 201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Tachibana M, Kobayashi Y, Matsushima Y (2003) Mouse models for four types of Waardenburg syndrome. Pigment Cell Res 16: 448–454. [DOI] [PubMed] [Google Scholar]
- 57. Scott G (2002) Rac and rho: the story behind melanocyte dendrite formation. Pigment Cell Res 15: 322–330. [DOI] [PubMed] [Google Scholar]
- 58. Zhang Z, Wu C, Wang S, Huang W, Zhou Z, et al. (2002) Cloning and characterization of ARHGAP12, a novel human rhoGAP gene. Int J Biochem Cell Biol 34: 325–331. [DOI] [PubMed] [Google Scholar]
- 59. Vartiainen M, Ojala PJ, Auvinen P, Peränen J, Lappalainen P (2000) Mouse A6/twinfilin is an actin monomer-binding protein that localizes to the regions of rapid actin dynamics. Mol Cell Biol 20: 1772–1783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Peng AW, Belyantseva IA, Hsu PD, Friedman TB, Heller S (2009) Twinfilin 2 regulates actin filament lengths in cochlear stereocilia. J Neurosci 29: 15083–15088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Morita K, Furuse M, Fujimoto K, Tsukita S (1999) Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. PNAS 96: 511–516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Wilcox ER, Burton QL, Naz S, Riazuddin S, Smith TN, et al. (2001) Mutations in the gene encoding tight junction claudin-14 cause recessive deafness DFNB29. Cell 104: 165–172. [DOI] [PubMed] [Google Scholar]
- 63. Ben-Yosef T, Belyantseva IA, Saunders TL, Hughes ED, Kawamoto K, et al. (2003) Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum. Molec Genet 12: 2049–2061. [DOI] [PubMed] [Google Scholar]
- 64. Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, et al. (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79: 949–957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Hou J (2012) The yin and yang of claudin-14 function in human diseases. Ann NY Acad Sci 1258: 185–190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Kozma R, Ahmed S, Best A, Lim L (1995) The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroplasts. Mol Cell Biol 15: 1942–1952. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Joberty G, Perlungher, R R, Macara, I G (1999) The Borgs, a new family of Cdc42 and TC10 GTPase-interacting proteins. Molec. Cell Biol 19: 6585–6597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Kim H, Kang K, Ekram MB, Roh TY, Kim J (2011) Aebp2 as an epigenetic regulator for neural crest cells. PLoS One 6: e25174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, et al. (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45: 1–14. [DOI] [PubMed] [Google Scholar]
- 70. Lovicu FJ, Kolle G, Yamada T, Little MH, McAvoy JW (2000) Expression of Crim1 during murine ocular development. Mech Dev 94: 261–265. [DOI] [PubMed] [Google Scholar]
- 71. Wilson WJ, Mills PC (2005) Brainstem auditory-evoked response in dogs. Am J Vet Res 66: 2177–2187. [DOI] [PubMed] [Google Scholar]
- 72. Strain GM, Green KD, Twedt AC, Tedford BL (1993) Brain stem auditory evoked potentials from bone stimulation in dogs. Am J Vet Res 54: 1817–1821. [PubMed] [Google Scholar]
- 73. Scheifele PM, Clark JG (2012) Electrodiagnostic evaluation of auditory function in the dog. Vet Clin Small Anim 42: 1241–1257. [DOI] [PubMed] [Google Scholar]
- 74. Bradbury PJ, Zhang Z, Kroon DE, Casstevens TM, Ramdoss Y, et al. (2007) TASSEL: software for association mapping of complex traits in diverse samples. Bioinformatics 23: 2633–2635. [DOI] [PubMed] [Google Scholar]
- 75. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.